Federal Register notice: FDA announces a 2/4 public workshop entitled Evaluating the Pressor Effects of Drugs.
Federal Register notice: FDA makes available a draft guidance entitled Nonmetastatic, Castration-Resistant Prostate Cancer: Considerations for Metasta...
The Government Accountability Office says laboratory testing of three dietary supplements marketed to improve memory did not contain ingredients and q...
FDA approves Stallergenes Greers Oralair (Sweet Vernal, Orchard, Perennial Rye, Timothy, and Kentucky Blue Grass mixed pollens allergen extract) for t...
FDA clears a Canon Medical Systems 510(k) for its new premium MRI system, Vantage Orian 1.5T.
FDA releases three International Medical Device Regulators Forum documents covering standards development, essential principles, and definitions.
FDA cautions healthcare professionals about the risks of using non-FDA approved pain medicines in implanted pumps.
Eli Lilly files an NDA for lasmiditan for the acute treatment of migraine and plans supplemental BLA for cluster headaches.